Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07815379
PHASE4

Standard Versus Double Alpha Blockers Treatment for Symptomatic Benign Prostatic Obstruction

Sponsor: Mansoura University

View on ClinicalTrials.gov

Summary

Failed medical treatment to alleviate LUTS and AUR is an indication for intervention, some trials were published elucidating the possible use of standard dose tamsulosin and silodosin and double dose tamsulosin but to the best of our knowledge, no studies with head-to-head comparison between Tamsulosin and Combination of Tamsulosin and Silodosin for Management of Lower Urinary Tract Symptoms and Acute Urine Retention in Patients with Benign Prostatic Hyperplasia.

Official title: Standard Versus Double Alpha Blockers Treatment for Symptomatic Benign Prostatic Obstruction: A Randomized Clinical Trial

Key Details

Gender

MALE

Age Range

40 Years - Any

Study Type

INTERVENTIONAL

Enrollment

140

Start Date

2025-10-12

Completion Date

2026-11

Last Updated

2026-09-11

Healthy Volunteers

No

Interventions

DRUG

alpha blocker monotherapy Tamsulosin

Effect of Tamsulosin and placebo in Management of Lower Urinary Tract Symptoms and Acute Urine Retention in Patients with Benign Prostatic Hyperplasia.

DRUG

alpha blockers Tamsulosin and Silodosin

BPH patients are given dual alpha blockers compared to single alpha blocker drug

Locations (1)

Urology and Nephrology Center, Mnasoura University

Al Mansurah, Dakahlia Governorate, Egypt